Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy

Annals of Internal Medicine

Volumn 164, Issue 2, 2016, Pages 93-101

  Mulrooney, Daniel A ^a,b,c,d   Armstrong, Gregory T ^a,b,c,d   Huang, Sujuan ^a,b,c,d   Ness, Kirsten K ^a,b,c,d   Ehrhardt, Matthew J ^a,b,c,d   Joshi, Vijaya M ^a,b,c,e   Plana, Juan Carlos ^a,b,c   Soliman, Elsayed Z ^a,b,c   Green, Daniel M ^a,b,c,d   Srivastava, Deokumar ^a,b,c,d   Santucci, Aimee ^a,b,c,d   Krasin, Matthew J ^a,b,c,d   Robison, Leslie L ^a,b,c,d   Hudson, Melissa M ^a,b,c  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IDARUBICIN; MITOXANTRONE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CARDIOTOXIN;

ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CALCIFICATION; CANCER DIAGNOSIS; CANCER SURVIVOR; CARCINOMA; CARDIOMYOPATHY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; CHILDHOOD OBESITY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GERM CELL TUMOR; GROUPS BY AGE; HODGKIN DISEASE; HUMAN; HYPERTENSION; LIVER CANCER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PHYSICAL INACTIVITY; PRIORITY JOURNAL; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; RADIATION DOSE; RADIATION EXPOSURE; RETINOBLASTOMA; SARCOMA; SMOKING; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE STENOSIS; ADOLESCENT; ADVERSE EFFECTS; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SURVIVOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CARDIOTOXINS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; RADIOTHERAPY; RISK FACTORS; SURVIVORS; UNITED STATES; YOUNG ADULT;

EID: 84955273557     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0424     Document Type: Article

References (46)

1. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2011. Accessed at http://seer.cancer.gov/archive/csr/1975-2009-pops09/ on 29 October 2015.
2. Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomarkers Prev. 2015; 24: 653-63. [PMID: 25834148]
3. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nat Rev Cancer. 2014; 14: 61-70. [PMID: 24304873]
4. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008; 100: 1368-79. [PMID: 18812549]
5. Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol. 2009; 27: 2328-38. [PMID: 19332714]
6. Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009; 339: b4606. [PMID: 19996459]
7. van der Pal HJ, van Dalen EC, van Delden E, van Dijk IW, Kok WE, Geskus RB, et al. High risk of symptomatic cardiac events in childhood cancer survivors. J Clin Oncol. 2012; 30: 1429-37. [PMID: 22473161]
8. Tukenova M, Guibout C, Oberlin O, Doyon F, Mousannif A, Haddy N, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010; 28: 1308-15. [PMID: 20142603]
9. Lipshultz SE, Landy DC, Lopez-Mitnik G, Lipsitz SR, Hinkle AS, Constine LS, et al. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. J Clin Oncol. 2012; 30: 1050-7. [PMID: 22393080]
10. van der Pal HJ, van Dalen EC, Hauptmann M, Kok WE, Caron HN, van den Bos C, et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. Arch Intern Med. 2010; 170: 1247-55. [PMID: 20660845]
11. Hudson MM, Ness KK, Nolan VG, Armstrong GT, Green DM, Morris EB, et al. Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer. 2011; 56: 825-36. [PMID: 21370418]
12. Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004; 22: 4979-90. [PMID: 15576413]
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al; Chamber Quantification Writing Group. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18: 1440-63. [PMID: 16376782]
14. Le Deley MC, Leblanc T, Shamsaldin A, Raquin MA, Lacour B, Sommelet D, et al; Société Française d'Oncologie Pédiatrique. Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Franc, aise d'Oncologie Pédiatrique. J Clin Oncol. 2003; 21: 1074-81. [PMID: 12637473]
15. Stovall M, Weathers R, Kasper C, Smith SA, Travis L, Ron E, et al. Dose reconstruction for therapeutic and diagnostic radiation exposures: use in epidemiological studies. Radiat Res. 2006; 166: 141-57. [PMID: 16808603]
16. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al; American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003; 16: 777-802. [PMID: 12835667]
17. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al; American Society of Echocardiography. Echocardio- graphic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009; 22: 1-23. [PMID: 19130998]
18. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: John Wright-PSG; 1982.
19. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111-7. [PMID: 12091180]
20. Pollentier B, Irons SL, Benedetto CM, Dibenedetto AM, Loton D, Seyler RD, et al. Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J. 2010; 21: 13-21. [PMID: 20467515]
21. Ratitch B, Lipkovich I, O'Kelly M. Combining analysis results from multiply imputed categorical data. Presented at PharmaSUG 2013, Chicago, Illinois, 12-15 May 2013. Paper SP03. Accessed at http://pharmasug.org/proceedings/2013/SP/PharmaSUG-2013-SP03 .pdf on 30 October 2015.
22. Kremer LC, van Dalen EC, Offringa M, Ottenkamp J, Voɥte PA. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001; 19: 191-6. [PMID: 11134212]
23. van Dalen EC, van der Pal HJ, Kok WE, Caron HN, Kremer LC. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. Eur J Cancer. 2006; 42: 3191-8. [PMID: 16987655]
24. Pein F, Sakiroglu O, Dahan M, Lebidois J, Merlet P, Shamsaldin A, et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer. 2004; 91: 37-44. [PMID: 15162142]
25. Velensek V, Mazic U, Krzisnik C, Demsar D, Jazbec J, Jereb B. Cardiac damage after treatment of childhood cancer: a long-term follow-up. BMC Cancer. 2008; 8: 141. [PMID: 18492236]
26. Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al. Clinical ascertainment of health outcomes among adults treated for childhood cancer. JAMA. 2013; 309: 2371-81. [PMID: 23757085]
27. Kremer LC, van der Pal HJ, Offringa M, van Dalen EC, Voɥte PA. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol. 2002; 13: 819-29. [PMID: 12123328]
28. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003; 289: 194-202. [PMID: 12517230]
29. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of asymptomatic left ventricular systolic dysfunction in the community. Circulation. 2003; 108: 977-82. [PMID: 12912813]
30. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992; 327: 685-91. [PMID: 1463530]
31. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119: e391-479. [PMID: 19324966]
32. Adams MJ, Lipsitz SR, Colan SD, Tarbell NJ, Treves ST, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol. 2004; 22: 3139-48. [PMID: 15284266]
33. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013; 368: 987-98. [PMID: 23484825]
34. King V, Constine LS, Clark D, Schwartz RG, Muhs AG, Henzler M, et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1996; 36: 881-9. [PMID: 8960517]
35. Mulrooney DA, Nunnery SE, Armstrong GT, Ness KK, Srivastava D, Donovan FD, et al. Coronary artery disease detected by coronary computed tomography angiography in adult survivors of childhood Hodgkin lymphoma. Cancer. 2014; 120: 3536-44. [PMID: 25041978]
36. Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003; 42: 743-9. [PMID: 12932613]
37. van der Pal HJ, van Dijk IW, Geskus RB, Kok WE, Koolen M, Sieswerda E, et al. Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study. Int J Radiat Oncol Biol Phys. 2015; 91: 213-22. [PMID: 25442333]
38. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a populationbased study. Lancet. 2006; 368: 1005-11. [PMID: 16980116]
39. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999; 83: 897-902. [PMID: 10190406]
40. Reid CL, Anton-Culver H, Yunis C, Gardin JM. Prevalence and clinical correlates of isolated mitral, isolated aortic regurgitation, and both in adults aged 21 to 35 years (from the CARDIA study). Am J Cardiol. 2007; 99: 830-4. [PMID: 17350376]
41. Travis LB, Ng AK, Allan JM, Pui CH, Kennedy AR, Xu XG, et al. Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst. 2012; 104: 357-70. [PMID: 22312134]
42. Armstrong GT, Oeffinger KC, Chen Y, Kawashima T, Yasui Y, Leisenring W, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013; 31: 3673-80. [PMID: 24002505]
43. Landier W, Armenian SH, Lee J, Thomas O, Wong FL, Francisco L, et al. Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines. J Clin Oncol. 2012; 30: 4401-8. [PMID: 23091100]
44. Wong FL, Bhatia S, Landier W, Francisco L, Leisenring W, Hudson MM, et al. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med. 2014; 160: 672-83. [PMID: 24842414]
45. Yeh JM, Nohria A, Diller L. Routine echocardiography screening for asymptomatic left ventricular dysfunction in childhood cancer survivors: a model-based estimation of the clinical and economic effects. Ann Intern Med. 2014; 160: 661-71. [PMID: 24842413]
46. Ojha RP, Oancea SC, Ness KK, Lanctot JQ, Srivastava DK, Robison LL, et al. Assessment of potential bias from non-participation in a dynamic clinical cohort of long-term childhood cancer survivors: results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer. 2013; 60: 856-64. [PMID: 23024097] doi: 10.1002/pbc.24348